𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Multicenter Analysis of Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor for PB Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies

✍ Scribed by Awan, Farrukh Tauseef; Kochuparambil, Samith; Craig, Michael; Cumpston, Aaron; Leadmon, Sonia; DeRemer, David; Watkins, Kathy; Pantin, Jeremy; Kota, Vamsi; Jillella, Anand; Hamadani, Mehdi

Book ID
121970402
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
145 KB
Volume
19
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Peripheral blood progenitor cell mobiliz
Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage–colony-stimulating factor and granulocyte–colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation
✍ Asad Bashey; Michael Donohue; Lin Liu; Bridget Medina; Sue Corringham; Anita Iha πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 150 KB
Plerixafor Plus Granulocyte Colony-Stimu
Plerixafor Plus Granulocyte Colony-Stimulating Factor versus Placebo Plus Granulocyte Colony-Stimulating Factor for Mobilization of CD34+ Hematopoietic Stem Cells in Patients with Multiple Myeloma and Low Peripheral Blood CD34+ Cell Count: Results of a Subset Analysis of a Randomized Trial
✍ Nademanee, Auayporn P.; DiPersio, John F.; Maziarz, Richard T.; Stadtmauer, Edwa πŸ“‚ Article πŸ“… 2012 πŸ› Elsevier Science 🌐 English βš– 588 KB
Ifosamide, epirubicin and granulocyte co
Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma
✍ M. Arland; S. Leuner; S. Lange; R. Bartsch; C. Kahl; A. FlorschΓΌtz; A. Franke; H πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 67 KB

## Abstract In general, the mobilization of peripheral blood progenitor cells (PBPC) in multiple myeloma (MM) patients is poor and is achieved in most cases by combined cyclophosphamide and G‐CSF. This study was performed to examine the efficacy of combined ifosfamide/epirubicine and G‐CSF for PBPC